Atlas Trials

Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer

Clinical trial NCT07325565 · RECRUITING

Trial details

NCT number
NCT07325565
Sponsor
Tongji Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Liver CancerEmotional Disorder
Start date
2025-12-20
Primary completion
2027-12-31
Enrollment
651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.